ACS Biomarker BV (cardiovascular biomarkers) has raised an undisclosed amount through its Series A venture round. Life Sciences Fund and Limburg Ventures were the investors and will each contribute one board member. (May)
ACS, a 2007 spin-off from the Maastricht University Medical Centre, will use the proceeds to discover and further develop biomarkers...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?